Changes in cardiovascular risk factors by combined pharmacological and nonpharmacological strategies: The main results of the CELL study

Journal of Internal Medicine

Volumn 240, Issue 1, 1996, Pages 13-22

  Lindholm, Lars H ^a   Ekbom, Tord ^b   Dash, Clive ^b   Isacsson, Åke ^b   Scherstén, Bengt ^b  

^a LUND UNIVERSITY   (Sweden)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; PRAVASTATIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; HUMAN; HYPERLIPIDEMIA; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATIENT COUNSELING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SWEDEN;

EID: 0030036537     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.1996.492831000.x     Document Type: Article

References (28)

1. Rose G, Heller RF, Tunstall-Pedoe H, Christie DG. Heart disease prevention project: a randomised controlled trial in industry. Br Med J 1980; 280: 747-51.
2. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383-9.
3. European Atherosclerosis Society Study Group. The recognition and management of hyperlipidaemia in adults: A policy statement of the European Atherosclerosis Society. Eur Heart J 1988; 9: 571-600.
4. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Summary of the second report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. JAMA 1993; 269: 3015-23.
5. Kannel WB, Wolf PA. Putting it all together: changing the cardiovascular outlook. Am Heart J 1992; 123: 264-7.
6. Tyroler HA. Overview of clinical trials of cholesterol lowering in relationship to epidemiological studies. Am J Med 1989; 87(Suppl. 4A): 14-95.
7. Johannesson M, Borgquist L, Nilsson-Ehle P, Ekbom T, Lindholm L. The cost of screening for hyperlipidaemia - results from a clinical trial in Swedish primary health care. Scand J Clin Lab Invest 1993; 53: 725-32.
8. Lindholm LH, Ekbom T, Dash C, Ericsson M, Tibblin G, Scherstén B, for the CELL Study Group. The impact of health care given in primary care on cardiovascular risk. Br Med J 1995; 310: 1105-9.
9. McTavish D, Sorkin EM, Pravastatin: a review of its pharmacological properties and therapeutic potential in hypercholesterolaemia. Drugs 1991; 42: 65-89.
10. Nakaya N, Homma Y, Tamachi H, Shigematsu H, Hata Y, Goto Y. The effect of CS-514 on serum lipids and apolipoproteins in hypercholesterolaemic subjects. JAMA 1987; 257: 3088-93.
11. Turpeinen O, Karvonen MJ, Pekkarinen M, Miettinen M, Elosuo R, Paavilainen E. Dietary prevention of coronary heart disease: the Finnish mental hospital study. Int J Epidemiol 1979; 8: 99-118.
12. Leren P. The effects of plasma cholesterol lowering diet in the male survivors of myocardial infarction. Acta Med Scand 1966; 446(Suppl.): 1-92.
13. Research Committee to the Medical Research Council. Controlled trial of soya-bean oil in myocardial infarction. Lancet 1968; ii: 693-700.
14. Kannel WB, Wolf PA, Garrison RJ, eds. The Framingham Study: an epidemiological investigation of cardiovascular disease, section 37. The probability of developing certain cardiovascular diseases in eight years at specified values of some characteristics. Springfield, IL: US Department of Commerce, National Technical Information Service, 1987.
15. Ekbom T, Lindholm LH, Lanke J, Nilsson-Ehle P. Decrease in high-density lipoprotein cholesterol during prolonged storage. Scand J Clin Lab Invest 1996; 56: 97-101.
16. Danielsson H, Ekman R, Fex G, Johansson BG, Kristensson H. Changes in plasma high density lipoproteins in chronic male alcoholics during and after abuse. Scand J Clin Lab Invest 1978; 38: 113-19.
17. Roeschlau P, Bernt E, Gruber W. Enzymatische bestimmungen des Gesamtcholesterins in Serum. Zeitsch Klin Chem Klin Biochem 1974; 12: 226-30.
18. Wahlefeld AW. Triglyceride determination after enzymatic hydrolysis. In: Bergmayer HV, ed. Methods of Enzymatic Analysis. New York: Verlag Chemie and Academic Press, 1974; 1874.
19. Friedewald WT, Levy RI, Frederickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without the use of a preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
20. Axland C, Tryding N. Reflotron in primary health care. Results obtained by personnel without laboratory experience. In: Marks V, Alberti KGMM, eds. Clinical Biochemistry Nearer the Patient II. London: Bailliere Tindall, 1986; 140-41.
21. Tryding N. Decentralised testing in primary care: Swedish experiences. Health Economics. Advanced Hospital Technology 1990; 2: 29-32.
22. Drug Information Committee. Treatment of mild hypertension. Sweden: National Board of Health and Welfare, 1987; 1: 1-199.
23. Wiklund I, Tibblin G, Dimnäs E. Quality of life and hypertension. Where do we stand? New methods, new possibilities. Definition and measurement of quality of life from a medical perspective. Scand J Prim Health Care 1990; Suppl. 1.
24. Lipid Research Clinics Program. The lipid research clinics coronary primary prevention trial results. II The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. JAMA 1984; 251: 365-74.
25. Ramsay LE, Yeo WW, Jackson PR. Dietary reduction of serum cholesterol concentration: time to think again. Br Med J 1991; 303: 953-7.
26. Family Health Study Group. Randomised controlled trial evaluating cardiovascular screening and intervention in general practice; principal results of British Family Heart Study. Br Med J 1994; 308: 313-20.
27. Imperial Cancer Research Fund OXCHECK Study Group. Effectiveness of health checks conducted by nurses in primary care: results of the OXCHECK study after one year. Br Med J 1994; 308: 308-12.
28. Imperial Cancer Research Fund OXCHECK Study Group. Effectiveness of health checks conducted by nurses in primary care: final results of the OXCHECK study. Br Med J 1995; 310: 1099-104.